Michelle Xu is an associate professor at the School of Basic Medical Sciences and Institute for Immunology, Tsinghua University. She received her Bachelor of Pharmacology from Capital Medical University in 2007 and earned her PhD in Cell Biology from the Institute of Biophysics, Chinese Academy of Sciences in 2012. From 2013 to 2017, she conducted postdoctoral research at the University of Chicago. In early 2018, she returned to Tsinghua University to establish an independent research group. Xu’s research team investigates the complex interactions between immune cells, tumor cells and tumor microenvironment (TME) in different cancer settings, thereby developing novel anticancer immunotherapies to improve clinical benefit. Her work particularly delves into how tumor cells evade immune surveillance by co-opting RNA modification programs found in both tumor cells and host immune cells.